|
For Severe Asthma, Most Surveyed U.S. Payers Would Reimburse a Novel …
PR Newswire (press release) Surveyed U.S. and European pulmonologists agree that reduction in rate of exacerbations is the attribute that most influences prescribing decisions in moderate to severe asthma. Clinical data and the opinions of interviewed thought leaders indicate … |
View full post on asthma – Google News